Skip to main content
DR REDDYS LABORATORIES LTD logo

DR REDDYS LABORATORIES LTD — Investor Relations & Filings

Ticker · RDY ISIN · US2561352038 LEI · 335800OVDPY3DVZR2798 BSE.NS Manufacturing
Filings indexed 2,316 across all filing types
Latest filing 2026-03-10 Regulatory Filings
Country IN India
Listing BSE.NS RDY

About DR REDDYS LABORATORIES LTD

https://www.drreddys.com/

Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company focused on providing affordable and innovative medicines. The company's core activities include the development, manufacturing, and marketing of a broad portfolio of products. This portfolio encompasses Active Pharmaceutical Ingredients (APIs), generic and branded-generic formulations, over-the-counter (OTC) products, and biologics. In addition to its significant presence in the generics market, the company invests in the research and development of novel molecules and proprietary products, with a focus on therapeutic areas such as dermatology and neurology. Dr. Reddy's is also committed to sustainable operations, actively working to reduce its environmental footprint through initiatives in water conservation, waste reduction, and decarbonisation.

Recent filings

Filing Released Lang Actions
Clarification on news article
Regulatory Filings
2026-03-10 English
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings
2026-03-10 English
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings
2026-03-06 English
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
Regulatory Filings
2026-03-05 English
Intimation of Analyst meet
Regulatory Filings
2026-02-27 English
Disclosure under Regulation 30 of the SEBI Listing Regulations
Regulatory Filings
2026-02-24 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.